Please use this identifier to cite or link to this item:
|Title:||Building Effective Institutional Frameworks to Support European Pharmacogenetic Research: an International Empirical Analysis|
|Authors:||GAISSER Sibylle; DREILING Marieke; HARTIG Juliane; HOPKINS Michael; JIM Ryan; IBARRETA RUIZ Dolores|
|Citation:||International Journal of Biotechnology (IJBT) vol. 10 no. 6 p. 552-569|
|Publisher:||Inderscience Enterprises Ltd.|
|Type:||Articles in periodicals and books|
|Abstract:||As science unravels the role of genetic factors in disease and treatment response the opportunities offered by pharmacogenetics and pharmacoge-nomics (PGx) for future healthcare become more and more apparent. The objective of this paper is to analyze the current state of PGx research and to explore future strategies for more efficient research projects and suppor-tive infrastructures. Based on internet searches and an online survey of public research groups, the current focus of PGx technology, and institu-tional framework conditions for its performance were determined. The main areas of PGx research are the liver, neoplasms, the cardiovascular and central nervous systems. Collaborations are important for knowledge transfer between the private and the public sector. However, for strategic and confidentiality reasons most collaborations are restricted to preclinical development, early stage clinical studies and the development of methods|
|JRC Institute:||Growth and Innovation|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.